Calcium Channel Blocker (CCB) Amlodipine Besylate Therapy is Associated with Reduced Case Fatality Rate of COVID-19 Patients with Hypertension
ViewEfficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study
ViewPhase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise.
ViewOral ondansetron for paediatric gastroenteritis in primary care: a randomised controlled trial
ViewTelmisartan inhibits the NLRP3 inflammasome by activating the PI3K pathway in neural stem cells injured by oxygen-glucose deprivation (OGD)
ViewEfficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI): a meta-analysis of randomized controlled trials with GRADE qualification of available evidence
ViewVildagliptin is a safe and powerful oral antidiabetic drug for elderly adults with type 2 diabetes
ViewThe efficacy and safety of azithromycin in chronic respiratory diseases related cough
ViewEffect of Rosuvastatin on Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Prospective Interventional Study
ViewThe impact of vildagliptin on the daily glucose profle and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE—A multicenter randomized controlled trial
View